Activity Spreadsheet -- Enzyme Inhibition Constant Data from BindingDB (change energy unit to kcal/mol)
Found 159 hits in this display
BDBM50399540(FORETINIB | US10464902, Foretinib | US10882853, Co...)
BDBM50399540(FORETINIB | US10464902, Foretinib | US10882853, Co...)
BDBM50399540(FORETINIB | US10464902, Foretinib | US10882853, Co...)
BDBM50399540(FORETINIB | US10464902, Foretinib | US10882853, Co...)
BDBM50399540(FORETINIB | US10464902, Foretinib | US10882853, Co...)
Ki: 60nMAssay Description:Displacement of [3H]-cyclopamine from human wild-type SMO receptor expressed in HEK293T cell membranes by liquid scintillation spectrometryMore data for this Ligand-Target Pair
BDBM50399540(FORETINIB | US10464902, Foretinib | US10882853, Co...)
BDBM50399540(FORETINIB | US10464902, Foretinib | US10882853, Co...)
BDBM50399540(FORETINIB | US10464902, Foretinib | US10882853, Co...)
BDBM50399540(FORETINIB | US10464902, Foretinib | US10882853, Co...)
BDBM50399540(FORETINIB | US10464902, Foretinib | US10882853, Co...)
BDBM50399540(FORETINIB | US10464902, Foretinib | US10882853, Co...)
BDBM50399540(FORETINIB | US10464902, Foretinib | US10882853, Co...)
BDBM50399540(FORETINIB | US10464902, Foretinib | US10882853, Co...)
BDBM50399540(FORETINIB | US10464902, Foretinib | US10882853, Co...)
BDBM50399540(FORETINIB | US10464902, Foretinib | US10882853, Co...)
BDBM50399540(FORETINIB | US10464902, Foretinib | US10882853, Co...)
BDBM50399540(FORETINIB | US10464902, Foretinib | US10882853, Co...)
BDBM50399540(FORETINIB | US10464902, Foretinib | US10882853, Co...)
BDBM50399540(FORETINIB | US10464902, Foretinib | US10882853, Co...)
BDBM50399540(FORETINIB | US10464902, Foretinib | US10882853, Co...)
BDBM50399540(FORETINIB | US10464902, Foretinib | US10882853, Co...)
BDBM50399540(FORETINIB | US10464902, Foretinib | US10882853, Co...)
BDBM50399540(FORETINIB | US10464902, Foretinib | US10882853, Co...)
BDBM50399540(FORETINIB | US10464902, Foretinib | US10882853, Co...)
BDBM50399540(FORETINIB | US10464902, Foretinib | US10882853, Co...)
BDBM50399540(FORETINIB | US10464902, Foretinib | US10882853, Co...)
BDBM50399540(FORETINIB | US10464902, Foretinib | US10882853, Co...)
IC50: 1.10nMAssay Description:Inhibition of c-MET (unknown origin) using poly (Glu, Tyr) (4:1) as substrate after 30 mins by spectrophotometric analysisMore data for this Ligand-Target Pair
BDBM50399540(FORETINIB | US10464902, Foretinib | US10882853, Co...)
BDBM50399540(FORETINIB | US10464902, Foretinib | US10882853, Co...)
BDBM50399540(FORETINIB | US10464902, Foretinib | US10882853, Co...)
BDBM50399540(FORETINIB | US10464902, Foretinib | US10882853, Co...)
BDBM50399540(FORETINIB | US10464902, Foretinib | US10882853, Co...)
IC50: 1.20nMAssay Description:Inhibition of c-Met (unknown origin) using poly (Glu,Tyr)4:1 as substrate by homogeneous time-resolved fluorescence assayMore data for this Ligand-Target Pair
BDBM50399540(FORETINIB | US10464902, Foretinib | US10882853, Co...)
BDBM50399540(FORETINIB | US10464902, Foretinib | US10882853, Co...)
IC50: 1.20nMAssay Description:Inhibition of c-Met kinase (unknown origin) using poly(glu,Tyr)4:1 as substrate incubated for 30 mins by homogeneous time-resolved fluorescence assayMore data for this Ligand-Target Pair
BDBM50399540(FORETINIB | US10464902, Foretinib | US10882853, Co...)
BDBM50399540(FORETINIB | US10464902, Foretinib | US10882853, Co...)
BDBM50399540(FORETINIB | US10464902, Foretinib | US10882853, Co...)
BDBM50399540(FORETINIB | US10464902, Foretinib | US10882853, Co...)
BDBM50399540(FORETINIB | US10464902, Foretinib | US10882853, Co...)
BDBM50399540(FORETINIB | US10464902, Foretinib | US10882853, Co...)
BDBM50399540(FORETINIB | US10464902, Foretinib | US10882853, Co...)
BDBM50399540(FORETINIB | US10464902, Foretinib | US10882853, Co...)
BDBM50399540(FORETINIB | US10464902, Foretinib | US10882853, Co...)
BDBM50399540(FORETINIB | US10464902, Foretinib | US10882853, Co...)
BDBM50399540(FORETINIB | US10464902, Foretinib | US10882853, Co...)
BDBM50399540(FORETINIB | US10464902, Foretinib | US10882853, Co...)
BDBM50399540(FORETINIB | US10464902, Foretinib | US10882853, Co...)
BDBM50399540(FORETINIB | US10464902, Foretinib | US10882853, Co...)
IC50: 1.80nMAssay Description:Inhibition of c-MET (unknown origin) using FAM-labeled peptide as substrate incubated for 10 mins followed by substrate addition by HTRF assayMore data for this Ligand-Target Pair
BDBM50399540(FORETINIB | US10464902, Foretinib | US10882853, Co...)
BDBM50399540(FORETINIB | US10464902, Foretinib | US10882853, Co...)
BDBM50399540(FORETINIB | US10464902, Foretinib | US10882853, Co...)
BDBM50399540(FORETINIB | US10464902, Foretinib | US10882853, Co...)
BDBM50399540(FORETINIB | US10464902, Foretinib | US10882853, Co...)
BDBM50399540(FORETINIB | US10464902, Foretinib | US10882853, Co...)
BDBM50399540(FORETINIB | US10464902, Foretinib | US10882853, Co...)
IC50: 1.90nMAssay Description:Inhibition of c-MET (unknown origin) using poly (Glu, Tyr) 4:1 as substrate after 30 mins in presence of ATP by HTRF assayMore data for this Ligand-Target Pair
BDBM50399540(FORETINIB | US10464902, Foretinib | US10882853, Co...)
BDBM50399540(FORETINIB | US10464902, Foretinib | US10882853, Co...)
BDBM50399540(FORETINIB | US10464902, Foretinib | US10882853, Co...)
IC50: 2.20nMAssay Description:Inhibition of c-MET (unknown origin) using poly (Glu, Tyr)4:1 as substrate in presence of ATP measured after 30 mins by HTRF assayMore data for this Ligand-Target Pair
BDBM50399540(FORETINIB | US10464902, Foretinib | US10882853, Co...)
BDBM50399540(FORETINIB | US10464902, Foretinib | US10882853, Co...)
BDBM50399540(FORETINIB | US10464902, Foretinib | US10882853, Co...)
BDBM50399540(FORETINIB | US10464902, Foretinib | US10882853, Co...)
BDBM50399540(FORETINIB | US10464902, Foretinib | US10882853, Co...)
BDBM50399540(FORETINIB | US10464902, Foretinib | US10882853, Co...)
BDBM50399540(FORETINIB | US10464902, Foretinib | US10882853, Co...)
BDBM50399540(FORETINIB | US10464902, Foretinib | US10882853, Co...)
IC50: 3nMAssay Description:Inhibition of wildtype human TRKA using poly (Glu,Tyr) 4:1 as substrate in presence of [gamma-33P]ATP by hotspot kinase assayMore data for this Ligand-Target Pair
BDBM50399540(FORETINIB | US10464902, Foretinib | US10882853, Co...)
BDBM50399540(FORETINIB | US10464902, Foretinib | US10882853, Co...)
BDBM50399540(FORETINIB | US10464902, Foretinib | US10882853, Co...)
BDBM50399540(FORETINIB | US10464902, Foretinib | US10882853, Co...)
IC50: 3.20nMAssay Description:Inhibition of recombinant c-Met (unknown origin) using poly (Glu, Tyr) 4:1 as substrate incubated for 60 mins by ELISAMore data for this Ligand-Target Pair
BDBM50399540(FORETINIB | US10464902, Foretinib | US10882853, Co...)
BDBM50399540(FORETINIB | US10464902, Foretinib | US10882853, Co...)
BDBM50399540(FORETINIB | US10464902, Foretinib | US10882853, Co...)
BDBM50399540(FORETINIB | US10464902, Foretinib | US10882853, Co...)
BDBM50399540(FORETINIB | US10464902, Foretinib | US10882853, Co...)
IC50: 3.52nMpH: 7.0 T: 2°CAssay Description:The c-Met kinase activity was evaluated by homogeneous time-resolved fluorescence (HTRF) assays. In a 384-well plate, 20 µg/mL (Glue, Tyr) 4:1 w...More data for this Ligand-Target Pair
BDBM50399540(FORETINIB | US10464902, Foretinib | US10882853, Co...)
BDBM50399540(FORETINIB | US10464902, Foretinib | US10882853, Co...)
BDBM50399540(FORETINIB | US10464902, Foretinib | US10882853, Co...)
BDBM50399540(FORETINIB | US10464902, Foretinib | US10882853, Co...)
BDBM50399540(FORETINIB | US10464902, Foretinib | US10882853, Co...)
BDBM50399540(FORETINIB | US10464902, Foretinib | US10882853, Co...)
BDBM50399540(FORETINIB | US10464902, Foretinib | US10882853, Co...)
BDBM50399540(FORETINIB | US10464902, Foretinib | US10882853, Co...)
IC50: 3.90nMAssay Description:Inhibition of Ron (unknown origin) using poly (Glu, Tyr)4:1 as substrate in presence of ATP measured after 30 mins by HTRF assayMore data for this Ligand-Target Pair
BDBM50399540(FORETINIB | US10464902, Foretinib | US10882853, Co...)
BDBM50399540(FORETINIB | US10464902, Foretinib | US10882853, Co...)
BDBM50399540(FORETINIB | US10464902, Foretinib | US10882853, Co...)
IC50: 4.30nMAssay Description:Inhibition of VEGFR 2 (unknown origin) using poly (Glu, Tyr)4:1 as substrate in presence of ATP measured after 30 mins by HTRF assayMore data for this Ligand-Target Pair
BDBM50399540(FORETINIB | US10464902, Foretinib | US10882853, Co...)
BDBM50399540(FORETINIB | US10464902, Foretinib | US10882853, Co...)
BDBM50399540(FORETINIB | US10464902, Foretinib | US10882853, Co...)
IC50: 4.86nMpH: 7.0 T: 2°CAssay Description:The c-Met kinase activity was evaluated by homogeneous time-resolved fluorescence (HTRF) assays. In a 384-well plate, 20 µg/mL (Glue, Tyr) 4:1 w...More data for this Ligand-Target Pair
BDBM50399540(FORETINIB | US10464902, Foretinib | US10882853, Co...)
BDBM50399540(FORETINIB | US10464902, Foretinib | US10882853, Co...)
BDBM50399540(FORETINIB | US10464902, Foretinib | US10882853, Co...)
BDBM50399540(FORETINIB | US10464902, Foretinib | US10882853, Co...)
IC50: 5nMAssay Description:Inhibition of FLT-4 (unknown origin) using poly (Glu, Tyr)4:1 as substrate in presence of ATP measured after 30 mins by HTRF assayMore data for this Ligand-Target Pair
BDBM50399540(FORETINIB | US10464902, Foretinib | US10882853, Co...)
IC50: 5.20nMAssay Description:Inhibition of FLT-3 (unknown origin) using poly (Glu, Tyr)4:1 as substrate in presence of ATP measured after 30 mins by HTRF assayMore data for this Ligand-Target Pair
BDBM50399540(FORETINIB | US10464902, Foretinib | US10882853, Co...)
BDBM50399540(FORETINIB | US10464902, Foretinib | US10882853, Co...)
IC50: 5.5nMAssay Description:Inhibition of PDGFR alpha (unknown origin) using poly (Glu, Tyr)4:1 as substrate in presence of ATP measured after 30 mins by HTRF assayMore data for this Ligand-Target Pair
BDBM50399540(FORETINIB | US10464902, Foretinib | US10882853, Co...)
BDBM50399540(FORETINIB | US10464902, Foretinib | US10882853, Co...)
BDBM50399540(FORETINIB | US10464902, Foretinib | US10882853, Co...)
BDBM50399540(FORETINIB | US10464902, Foretinib | US10882853, Co...)
BDBM50399540(FORETINIB | US10464902, Foretinib | US10882853, Co...)
IC50: 5.61nMpH: 7.0 T: 2°CAssay Description:The c-Met kinase activity was evaluated by homogeneous time-resolved fluorescence (HTRF) assays. In a 384-well plate, 20 µg/mL (Glue, Tyr) 4:1 w...More data for this Ligand-Target Pair
BDBM50399540(FORETINIB | US10464902, Foretinib | US10882853, Co...)
IC50: 6.30nMAssay Description:Inhibition of c-Kit (unknown origin) using poly (Glu, Tyr)4:1 as substrate in presence of ATP measured after 30 mins by HTRF assayMore data for this Ligand-Target Pair
BDBM50399540(FORETINIB | US10464902, Foretinib | US10882853, Co...)
BDBM50399540(FORETINIB | US10464902, Foretinib | US10882853, Co...)
BDBM50399540(FORETINIB | US10464902, Foretinib | US10882853, Co...)
BDBM50399540(FORETINIB | US10464902, Foretinib | US10882853, Co...)
BDBM50399540(FORETINIB | US10464902, Foretinib | US10882853, Co...)
BDBM50399540(FORETINIB | US10464902, Foretinib | US10882853, Co...)
BDBM50399540(FORETINIB | US10464902, Foretinib | US10882853, Co...)
IC50: 6.72nMpH: 7.0 T: 2°CAssay Description:The c-Met kinase activity was evaluated by homogeneous time-resolved fluorescence (HTRF) assays. In a 384-well plate, 20 µg/mL (Glue, Tyr) 4:1 w...More data for this Ligand-Target Pair
BDBM50399540(FORETINIB | US10464902, Foretinib | US10882853, Co...)
IC50: 6.78nMpH: 7.0 T: 2°CAssay Description:The c-Met kinase activity was evaluated by homogeneous time-resolved fluorescence (HTRF) assays. In a 384-well plate, 20 µg/mL (Glue, Tyr) 4:1 w...More data for this Ligand-Target Pair
BDBM50399540(FORETINIB | US10464902, Foretinib | US10882853, Co...)
BDBM50399540(FORETINIB | US10464902, Foretinib | US10882853, Co...)
BDBM50399540(FORETINIB | US10464902, Foretinib | US10882853, Co...)
BDBM50399540(FORETINIB | US10464902, Foretinib | US10882853, Co...)
BDBM50399540(FORETINIB | US10464902, Foretinib | US10882853, Co...)
BDBM50399540(FORETINIB | US10464902, Foretinib | US10882853, Co...)
IC50: 6.89nMpH: 7.0 T: 2°CAssay Description:The c-Met kinase activity was evaluated by homogeneous time-resolved fluorescence (HTRF) assays. In a 384-well plate, 20 µg/mL (Glue, Tyr) 4:1 w...More data for this Ligand-Target Pair
BDBM50399540(FORETINIB | US10464902, Foretinib | US10882853, Co...)
BDBM50399540(FORETINIB | US10464902, Foretinib | US10882853, Co...)
BDBM50399540(FORETINIB | US10464902, Foretinib | US10882853, Co...)
IC50: 9.20nMAssay Description:Inhibition of TPR-tagged met (unknown origin) expressed in mouse BAF3 cells assessed as inhibition of cell proliferation after 72 hrs by MTT assayMore data for this Ligand-Target Pair
BDBM50399540(FORETINIB | US10464902, Foretinib | US10882853, Co...)
BDBM50399540(FORETINIB | US10464902, Foretinib | US10882853, Co...)
BDBM50399540(FORETINIB | US10464902, Foretinib | US10882853, Co...)
BDBM50399540(FORETINIB | US10464902, Foretinib | US10882853, Co...)
BDBM50399540(FORETINIB | US10464902, Foretinib | US10882853, Co...)
IC50: 10.6nMAssay Description:1. Methods(1) 4 μL of prepared kinase buffer solution or 4 μL of kinase solution (100% inhibition control) were added into a 384-hole plate...More data for this Ligand-Target Pair
BDBM50399540(FORETINIB | US10464902, Foretinib | US10882853, Co...)
BDBM50399540(FORETINIB | US10464902, Foretinib | US10882853, Co...)
IC50: 11nMAssay Description:Inhibition of PDGFR beta (unknown origin) using poly (Glu, Tyr)4:1 as substrate in presence of ATP measured after 30 mins by HTRF assayMore data for this Ligand-Target Pair
BDBM50399540(FORETINIB | US10464902, Foretinib | US10882853, Co...)
BDBM50399540(FORETINIB | US10464902, Foretinib | US10882853, Co...)
BDBM50399540(FORETINIB | US10464902, Foretinib | US10882853, Co...)
BDBM50399540(FORETINIB | US10464902, Foretinib | US10882853, Co...)
BDBM50399540(FORETINIB | US10464902, Foretinib | US10882853, Co...)
BDBM50399540(FORETINIB | US10464902, Foretinib | US10882853, Co...)
BDBM50399540(FORETINIB | US10464902, Foretinib | US10882853, Co...)
BDBM50399540(FORETINIB | US10464902, Foretinib | US10882853, Co...)
BDBM50399540(FORETINIB | US10464902, Foretinib | US10882853, Co...)
BDBM50399540(FORETINIB | US10464902, Foretinib | US10882853, Co...)
BDBM50399540(FORETINIB | US10464902, Foretinib | US10882853, Co...)
BDBM50399540(FORETINIB | US10464902, Foretinib | US10882853, Co...)
BDBM50399540(FORETINIB | US10464902, Foretinib | US10882853, Co...)
BDBM50399540(FORETINIB | US10464902, Foretinib | US10882853, Co...)
BDBM50399540(FORETINIB | US10464902, Foretinib | US10882853, Co...)
BDBM50399540(FORETINIB | US10464902, Foretinib | US10882853, Co...)
IC50: 214nMAssay Description:Inhibition of c-Met phosphorylation at Tyr 1234/Tyr1235 residues in human NCI-H1993 cells incubated for 4 hrs by HTRF assayMore data for this Ligand-Target Pair
BDBM50399540(FORETINIB | US10464902, Foretinib | US10882853, Co...)
BDBM50399540(FORETINIB | US10464902, Foretinib | US10882853, Co...)
BDBM50399540(FORETINIB | US10464902, Foretinib | US10882853, Co...)
IC50: 2.99E+3nMpH: 7.0 T: 2°CAssay Description:The c-Met kinase activity was evaluated by homogeneous time-resolved fluorescence (HTRF) assays. In a 384-well plate, 20 µg/mL (Glue, Tyr) 4:1 w...More data for this Ligand-Target Pair
BDBM50399540(FORETINIB | US10464902, Foretinib | US10882853, Co...)
BDBM50399540(FORETINIB | US10464902, Foretinib | US10882853, Co...)
BDBM50399540(FORETINIB | US10464902, Foretinib | US10882853, Co...)
BDBM50399540(FORETINIB | US10464902, Foretinib | US10882853, Co...)
BDBM50399540(FORETINIB | US10464902, Foretinib | US10882853, Co...)
BDBM50399540(FORETINIB | US10464902, Foretinib | US10882853, Co...)
IC50: 3.18E+3nMAssay Description:Inhibition of EGFR (unknown origin) using poly (Glu, Tyr)4:1 as substrate in presence of ATP measured after 30 mins by HTRF assayMore data for this Ligand-Target Pair
BDBM50399540(FORETINIB | US10464902, Foretinib | US10882853, Co...)
IC50: >5.00E+3nMAssay Description:Inhibition of ALK (unknown origin) using poly (Glu, Tyr)4:1 as substrate in presence of ATP measured after 30 mins by HTRF assayMore data for this Ligand-Target Pair
BDBM50399540(FORETINIB | US10464902, Foretinib | US10882853, Co...)
BDBM50399540(FORETINIB | US10464902, Foretinib | US10882853, Co...)
BDBM50399540(FORETINIB | US10464902, Foretinib | US10882853, Co...)
BDBM50399540(FORETINIB | US10464902, Foretinib | US10882853, Co...)
BDBM50399540(FORETINIB | US10464902, Foretinib | US10882853, Co...)
BDBM50399540(FORETINIB | US10464902, Foretinib | US10882853, Co...)
BDBM50399540(FORETINIB | US10464902, Foretinib | US10882853, Co...)
Displayed 1 to 50 (of 159 total ) | Next | Last >>